NASDAQ:ZIVO - Nasdaq - US98978N3098 - Common Stock - Currency: USD
1.1
-0.05 (-4.35%)
The current stock price of ZIVO is 1.1 USD. In the past month the price decreased by -67.26%. In the past year, price decreased by -93.39%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 23.29 | 138.82B | ||
HLN | HALEON PLC-ADR | 23.44 | 45.58B | ||
KVUE | KENVUE INC | 20.46 | 44.71B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 30.3 | 25.83B | ||
BRBR | BELLRING BRANDS INC | 35.08 | 9.36B | ||
COTY | COTY INC-CL A | 20.39 | 4.98B | ||
IPAR | INTERPARFUMS INC | 28.81 | 4.30B | ||
ELF | ELF BEAUTY INC | 23.86 | 4.23B | ||
ODD | ODDITY TECH LTD-CL A | 22.92 | 2.51B | ||
EPC | EDGEWELL PERSONAL CARE CO | 10.64 | 1.50B | ||
OLPX | OLAPLEX HOLDINGS INC | 10.92 | 941.35M | ||
HLF | HERBALIFE LTD | 4.24 | 837.56M |
Zivo Bioscience Inc is a US-based company operating in Personal Care Products industry. The company is headquartered in Bloomfield Hills, Michigan and currently employs 8 full-time employees. The company went IPO on 2000-10-06. Zivo Bioscience, Inc. is a research and development company. The firm operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its products include Poultry Gut Health, Bovine Mastitis, Canine Joint Health, Human Immune Modification, Algal biomass for human consumption and Biomass for supporting skin health / anti-aging. The firm is also engaged in licensing and selling natural bioactive ingredients derived from their algae cultures to animal, human and dietary supplement and medical food manufacturers. Its product candidates are at different stages of development for different applications.
ZIVO BIOSCIENCE INC
21 E. Long Lake Road, Suite 100
Bloomfield Hills MICHIGAN US
CEO: Andrew Dahl
Employees: 8
Company Website: https://zivobioscience.com/
Phone: 12484529866.0
The current stock price of ZIVO is 1.1 USD. The price decreased by -4.35% in the last trading session.
The exchange symbol of ZIVO BIOSCIENCE INC is ZIVO and it is listed on the Nasdaq exchange.
ZIVO stock is listed on the Nasdaq exchange.
7 analysts have analysed ZIVO and the average price target is 36.72 USD. This implies a price increase of 3238.18% is expected in the next year compared to the current price of 1.1. Check the ZIVO BIOSCIENCE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ZIVO BIOSCIENCE INC (ZIVO) has a market capitalization of 1.91M USD. This makes ZIVO a Nano Cap stock.
ZIVO BIOSCIENCE INC (ZIVO) currently has 8 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ZIVO does not pay a dividend.
ZIVO BIOSCIENCE INC (ZIVO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.58).
The outstanding short interest for ZIVO BIOSCIENCE INC (ZIVO) is 4.17% of its float. Check the ownership tab for more information on the ZIVO short interest.
Over the last trailing twelve months ZIVO reported a non-GAAP Earnings per Share(EPS) of -5.58. The EPS increased by 1.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -404.76% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to ZIVO. The Buy consensus is the average rating of analysts ratings from 7 analysts.